Male Urogenital Diseases clinical trials

Explore recruiting male urogenital diseases clinical trials.

Recruiting male urogenital diseases studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Male Urogenital Diseases trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection

France, Spain, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metastasis-directed therapy in oligoprogressive castration-refractory prostate cancer: a randomized phase 3 trial

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Interest of early erectile rehabilitation with Sildenafil after proctectomy for rectal cancer : Randomized controlled trial (RECTIL)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized phase II trial of docetaxel or cabazitaxel with or without darolutamide in men with metastatic castration-resistant prostate cancer.

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

Effectiveness and safety of combined autologous Platelet Rich Plasma and Focal Shockwave Therapy for the treatment of erectile dysfunction

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia Et klinisk interventionsforsøg

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Male Urogenital Diseases trials by city

Male Urogenital Diseases clinical trials

Recruiting male urogenital diseases studies right now

Efficacy and Safety of Telitacicept in IgAN

Deprescribing Intervention for Patients With Chronic Kidney Disease

A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study

A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients

Access Sheath and Stent Trial

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial

Refractory ANCA Associated Vasculitis and Lupus Nephritis Treated With BCMA-targeting CAR-T Cells

Disitamab Vedotin Plus Intravesical Mitomycin C in HER2-Expressing Intermediate- to High-Risk Non-Muscle-Invasive Bladder Cancer

Assessment of Women's Sexual Quality of Life After Benign Adnexal Surgery Using vNOTES Approach

Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer

Automated Insulin Delivery in Adults With Advanced Kidney Disease

Evaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer

Also recruiting in Europe

A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection

Metastasis-directed therapy in oligoprogressive castration-refractory prostate cancer: a randomized phase 3 trial

Interest of early erectile rehabilitation with Sildenafil after proctectomy for rectal cancer : Randomized controlled trial (RECTIL)

A randomized phase II trial of docetaxel or cabazitaxel with or without darolutamide in men with metastatic castration-resistant prostate cancer.

Effectiveness and safety of combined autologous Platelet Rich Plasma and Focal Shockwave Therapy for the treatment of erectile dysfunction

NT-NOA - Novel Treatment of some men with Non-Obstructive Azoospermia Et klinisk interventionsforsøg

Male Urogenital Diseases trials by city

Other conditions